Maimaitijiang, G., Watanabe, M., Shinoda, K., Isobe, N., Nakamura, Y., Masaki, K., . . . Kira, J. (2019). Long-term use of interferon-β in multiple sclerosis increases Vδ1(−)Vδ2(−)Vγ9(−) γδ T cells that are associated with a better outcome. J Neuroinflammation.
シカゴスタイル引用形Maimaitijiang, Guzailiayi, Mitsuru Watanabe, Koji Shinoda, Noriko Isobe, Yuri Nakamura, Katsuhisa Masaki, Takuya Matsushita, Yasunobu Yoshikai, , Jun-ichi Kira. "Long-term Use of Interferon-β in Multiple Sclerosis Increases Vδ1(−)Vδ2(−)Vγ9(−) γδ T Cells That Are Associated With a Better Outcome." J Neuroinflammation 2019.
MLA引用形式Maimaitijiang, Guzailiayi, et al. "Long-term Use of Interferon-β in Multiple Sclerosis Increases Vδ1(−)Vδ2(−)Vγ9(−) γδ T Cells That Are Associated With a Better Outcome." J Neuroinflammation 2019.